The ability of a polymer therapeutic to access the appropriate subcellular location is crucial to its efficacy, and is defined to a large part by the many and complex cellular biological and biochemical barriers such a construct must traverse. It is shown here that model dextrin conjugates are able to pass through a cartilaginous extracellular matrix into chondrocytes, with little perturbation of the matrix structure, indicating that targeting of potential therapeutics through a cartilaginous extracellular matrix should prove possible. Rapid chondrocytic targeting of drugs which require intracellularisation for their activity, and uniform extracellular concentrations of drugs with an extracellular target, is thus enabled though polymer conjugation.
Introduction
Articular cartilage lines the load bearing joints of the body acting to reduce friction and absorb mechanical loads. It is an aneural, avascular, hypocellular tissue, composed of a dense extracellular matrix controlled and secreted by the chondrocytes within it. The chondrocytes comprise less than 2% of the volume of mature articular cartilage with the remainder comprising a highly organised network of collagen fibrils, proteoglycans and water. The matrix macromolecules of articular cartilage give the tissue its unique structure and function. These structural macromolecules include collagens (mainly type II), proteoglycans and noncollagenous proteins. The type II collagen fibril meshwork gives the cartilage its form and tensile strength. The proteoglycans and non-collagenous proteins of articular cartilage bind to the collagen meshwork or become mechanically entrapped within it. The major proteoglycan of articular cartilage is aggrecan, which has numerous glycosaminoglycan chains attached to its core protein and forms huge multimolecular aggregates with hyaluronan and a link protein.
Hydration of the glycosaminoglycan chains of aggrecan provides cartilage with its compressibility functions.
More than ten million people in the UK have long-term health problems due to arthritis or a related condition 1 . The most common arthritic diseases are osteoarthritis and rheumatoid arthritis, both of which involve erosion of the cartilage cushioning the ends of bones within the joint. Symptoms include joint-pain and stiffness, which can lead to disability. Cartilage degeneration in arthritis is due ultimately to the enzymatic degradation of the cartilage extracellular matrix. The complexity and density of the cartilage extracellular matrix results in a barrier to the passage of molecules through the matrix, however its maintenance is crucial for tissue function. In the synovial joint the articular surface is lubricated and nourished by synovial fluid, a filtrate of blood plasma containing high levels of the glycosaminoglycan hyaluronan and the proteoglycan lubricin (SZP) 2 . The relative viscosity of synovial fluid provides an additional barrier to diffusion of molecules into chondrocytes.
1.
Arthritis and work (03.2017) http://www.arthritisresearchuk.org/policy-and-public-affairs/reports-andresources/reports/work-report.aspx 2. Rhee, D.K., Marcelino, J., Baker, M, Gong, Y., Smits, P., Lefebvre, V., Jay, G.D., Stewart, M., Wang, H., Warman, M.L. and Carpten, J.D. (2005) The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. The Journal of Clinical Current therapies for arthritis mainly treat the clinical disease symptoms rather than targeting the degradative enzymes themselves. Treatments such as steroidal and non-steroidal antiinflammatory drugs are still the mainstay of treatment 3 , 4 and can have adverse side effects including high blood pressure 5 , 6 , 7 , osteoporosis 8 , cataracts 9 , 10 and gastrointestinal bleeding 11 .
The newly released anti-TNF drugs (Etanercept, Infliximab and Adalimumab) which block the pro-inflammatory cytokine TNF in rheumatoid and psoriatic arthritis 12 , 13 are efficacious for only a small cohort of patients and are only prescribed for UK patients with severe and crippling forms of the disease as they carry the risk of serious side effects due to immuno-suppression 14 .
In recent years, a number of compounds have been identified, in in vitro studies, that are able to inhibit the initial loss of the extracellular matrix component aggrecan, via often unknown mechanistic inhibition of the proteases ADAMTS-4 and / or -5. These compounds have notably 32 . Conjugation of drugs to polymers has allowed for specific targeting of the therapeutic activity of a drug to the diseased tissue. This results in a reduction in the dose required for efficacy of treatment and a reduction in potential toxicity of the drugs.
Expanding this modality to the treatment of arthritic joints, requires that such polymers in order to deliver their drug payload must be able to pass through a cartilaginous extracellular matrix rich in negatively charged proteoglycans, either to reach their chondrocytic targets, or to achieve even distribution throughout the cartilage extracellular matrix. In the selection of suitable targeting polymers and polymer conjugates for the treatment of arthritic disease, quantifying whether these compounds can indeed pass through the barriers presented by the synovial joint without inducing their disruption will be of vital importance. Of the potential barriers present we believe that the interactions of polymers and polymer conjugates with proteoglycans, within the cartilage extracellular matrix as well as coating its surface, will be the most influential on their movement. This study focused on investigating the interactions of polymers and polymer conjugates with the cartilage proteoglycans aggrecan and lubricin as well as synovial fluid. 
Materials & Methods

Preparation of synovial fluid samples
Synovial fluid samples were harvested from the metacarpo / metatarso phalangeal joints of 18 month old cows legs using a 15 gauge needle.
Preparation of lubricin
Following effusion of the synovial fluid from the joints of 18 month old cows legs as described above the joints were lavaged using 1.6M sodium chloride to isolate the lubricin coating the surface of the articular cartilage 33 .
Preparation of aggrecan aggregates
Bovine articular cartilage explants were established using previous methodologies 34 . Following a 48 hour preculture explants were washed into serum free DMEM. The explants were then cultured in either (i) serum free DMEM or (ii) serum free DMEM + IL-1a (10ng/ml). Cultures were incubated for up to 96 hours; media and explants were harvested and finely diced prior to addition of guanidine extraction buffer (4M guanidine HCl, 50mM sodium acetate pH 5.8-6.8, 0.1M 6-amino-hexanoic acid, 5mM benzamidine HCl, 10mM ethylene diaminetetra acetic acid (EDTA) (tetrasodium salt), 1mM phenyl methyl sulphonyl fluoride (PMSF -10ml per gram cartilage wet weight) and incubated for 48 hours at 4 o C with constant agitation. The extracted cartilage debris was removed by centrifugation at 15,000rpm for 10 minutes, and discarded.
The liquid supernatant was then dialysed exhaustively against MilliQ™ water. The density of the extract was adjusted to 1.5g/ml by addition of CaCl 2 and aggrecan-hyaluronan aggregate purified by ultracentrifugation in a Beckman L-60 Ultracentrifuge at 37,000rpm for 70 hours at 4 o C. The extract was fractionated into 4 equal pools designated A1-A4, the lowest fraction A1
containing the purified aggrecan-hyaluronan complex and having a density >1.57g/ml. 
Analysis of cellular uptake of polymer conjugates by FACS and fluorescence microscopy
Explants were harvested and pre-cultured using previously established methods Error! Reference source not found. prior to incubation in the presence or absence of IL-1a (10ng/ml) for 96 hours 35 .
Cultures were then incubated in DMEM with 50µg/ml gentamicin and 10% (v/v) heat inactivated FBS in the presence or absence of Oregon Green labelled polymers at a range of concentrations (1-10µg/ml) for a number of time points (2-24 hours). Following incubation with polymers explants were either washed in phosphate buffered saline and viewed using a confocal microscope, or digested to free the cells using Pronase (1% {w/v} in DMEM containing 50µg/ml gentamicin and 10% {v/v} heat inactivated FBS) for 30 minutes at 37 o C, followed by collagenase type II (0.4% {w/v} in DMEM containing 50µg/ml gentamicin and 10% {v/v} heat inactivated FBS) for 45 minutes at 37 o C. The isolated cells will be pelleted by centrifugation resuspended in PBS and run on a FACs Canto (BD Biosciences).
Pulsed-Gradient Spin-Echo Nuclear Magnetic Resonance
Measurements on the purified freeze-dried aggrecan-hyaluronan complex redispersed in D 2 O were conducted on a Bruker AMX360 NMR spectrometer using a stimulated echo-sequence 36 .
This configuration used either a 5mm (Cryomagnet Systems, Indianapolis) or 10mm (Bruker) diffusion probe in conjunction with Bruker or Woodward gradient spectroscopy accessories.
The self-diffusion coefficient D s was extracted by fitting to equation 1 either (i) the integrals for a given peak, or (ii) the individual frequency channels present in the entire bandshape (CORE analysis);
(1) given that g is the magnetogyric ratio, D the diffusion time, σ the gradient ramp time, d the gradient pulse length and G the gradient field strength.
Small-angle neutron scattering
SANS experiments were performed on the LOQ diffractometer based at the spallation source at the Rutherford Appleton Laboratory, U.K., where a Q range of 0.007 Å -1 to 0. 
where P(Q) describes the morphology of the scattering species, S(Q) describes the spatial arrangement of the species in solution, N is the number of species per unit volume, V is the volume of the species, Δρ is the difference in the neutron scattering length density (SLD) of the scatterer and the solvent and B inc is the incoherent background scattering.
PGSE-NMR provides a convenient and non-invasive chemically selective technique for measuring translational motion, and in particular the self-, rather than mutual-diffusion coefficient. Therefore, PGSE-NMR can be used both to quantify the mobility of molecules and to assess the impact of the presence of the molecules on the extracellular matrix components themselves. The diffusion of small solutes (including water and Na + ) has been shown to be impeded by up to 40% by the presence of an extracellular matrix, implying that the movement of larger molecules such as polymers may be very significantly affected by the presence of a matrix 37 .
A vital component in the selection of polymer-drug conjugates for the treatment of arthritic disease is the selection of either polymers able to target a drug with intracellular activity and its ability to diffuse rapidly through the extracellular matrix into the chondrocyte. Accordingly, the rate of diffusion of dextrin polymers (as model conjugates) has been quantified both in free solution and through components of the cartilaginous extracellular matrix (an aggrecanhyaluronan aggregate gel purified by density gradient centrifugation from bovine articular cartilage), Table One . For the M w = 10k g/mol -1 dextrin sample, the self-diffusion coefficient was slowed from D s = 2.7 x 10 -10 m 2 s -1 in free solution, corresponding to a hydrodynamic radius of a few nanometres, to D s = 2.6 x 10 -11 m 2 s -1 in the aggrecan-hyaluronan gel, (Table 1) . The higher molecular weight dextrin shows a larger reduction, though the free solution retardation is consistent with the increase in molecular weight of a random coil configuration. By drawing analogies of the diffusion of such polymer in related (mucin) gels, this significant retardation is probably not a consequence of direct association of the dextrin with the aggrecan-hyaluronan aggregate, but rather steric hindrance due to the presence of the highly entangled matrix of the aggrecan-hyaluronan aggregate 38 . The non-linearity of the attenuation function clearly demonstrates the presence of more than a single diffusion rate and the CORE analysis identifies these to be dextrin (the initial decay) and the underlying much slower (two orders of magnitude slower) diffusion of the aggrecan-hyaluronan aggregates.
As an aside, we can also comment on the effect of succinoylation -the first step in dextrin functionalisation -on the conformation of the polymer, as characterised by their self-diffusion coefficients, figure 2. The self-diffusion coefficient drops smoothly (increasing hydrodynamic size) with increasing mole percent of succinoylation, up to a value of around ~10mol%, above which the self-diffusion coefficient becomes largely constant at ~1 x 10 -10 m 2 s -1 , consistent with an hydrodynamic radius of around 50Å.
The (gel) structure of cartilage extract, and various derivative materials have been examined by small-angle neutron scattering (SANS) in the absence and presence of added dextrin, figures 3a&b (representative data only presented). In the case of the 18m direct cartilage extract, where the scattering from the gel itself is significant (I(Q) > 10 cm -1 at Q < 0.01 Å) and
dominates the mixture scattering (for dextrin, I(Q) < 0.5 cm -1 at Q < 0.01 Å), addition of the two dextrin samples induced no noticeable perturbation in the scattering -and hence, structure of the direct cartilage extract gel. In the case of the IL-1 systems, and various other derivative materials (data not presented), figure 3b , the same conclusion may be drawn, but not so directly. It is obvious that the scattering does vary across the different mixed systems, but it is shown below that this is a consequence of the weaker and comparable intensities of the various components rather than one dominating contribution, as in the case of the 18m direct cartilage extract.
A number of strategies exist for interpreting SANS data. The simplest is to consider the slope of the data when plotted on a double logarithmic representation, extracting the so-called Q dependency, I(Q) µ Q -n , illustrating the most probable shape of the scatterer; n = 1 indicates a rod, n = 2 a flat structure, increasing all the way to n = 4 for a large, solid object. For systems like gels, one might anticipate n = 5/3 to the n = 3, reflecting a transition from a mass to volume fractal character associated with the differing length-scales present in the gel. This is indeed the case.
Alternatively, one may numerically analyse the data in terms of specific models, based on some a priori knowledge of the likely conformation or arrangement of molecules in solution. For dextrin, a simple polydisperse Gaussian coil model adequately describes the data for M w = 51K g/mol -1 dextrin sample, with R G = 80 Å (consistent with the theoretical prediction for the ratio of the radius of gyration and hydrodynamic radius, R G /R H = 1.5).
For the gels, an appropriate treatment is the Shibayama-Geissler two-length scale model 39 , 40 which treats the scattering as the additional of two components, with fraction f;
where D is the scaling exponent and * * ≈
. The parameters describing the Shibayama-Geissler fit to these data are presented in Table Two . By and large, the fitting is most sensitive to the Lorentzian component embodied in the scaling exponent D, with a length scale ( = * ) of around 100 Å, but the 18m direct cartilage extract also requires a Guinier term, with length scale slightly shorter. Most importantly, as is evident from the raw data where subtle differences are only observed at higher Q values, the parameters are largely insensitive to the addition of the dextrin i.e. it may be considered to be non-perturbing.
Having shown it is possible for dextrin to diffuse through the gel whilst having little impact on its structure, the progression of (Oregon Green fluorophore labelled) dextrin into chondrocytes was assessed. Each of the cultures was incubated in dextrin-Oregon Green at 1, 5 and 10µg/ml for 2-24 hours. Cells were released from monolayer cultures by gentle trypsinisation and by rapid pronase and collagenase digest from explant and ex vivo transwell grafts cultures. FACS analysis of these cell populations with 10µg/ml dextrin-Oregon Green at 2, 4, 8 and 24 hours are shown in Figure 4 .
Cellular uptake of the dextrin conjugate achieved in the presence of a cartilaginous extracellular matrix in both explant cultures and in ex vivo transwell grafts ( Figure 4B & A, respectively) . In cartilage explants cellular uptake was achieved in over 90% of cells following 8 hours exposure ( Figure 4B ). Uptake of dextrin-Oregon Green was slower in ex vivo transwell grafts than in explants cultures with only 66% of cells containing the fluorophore following 24 hours exposure ( Figure 4A ). In the ex vivo transwell grafts the dextrin-Oregon Green was only added to the insert medium to mimic the situation in vivo where a therapeutic agent injected into the joint would only be able to penetrate the cartilage at the articular surface ( Figure 5 ). This restricted access to one surface explains the apparently slower rate of uptake by chondrocytes within the ex vivo transwell grafts compared to chondrocytes within cartilage explants (Figures 4 A & B) .
In order to determine whether dextrin-Oregon Green was able to pass right through a cartilaginous extracellular matrix it was only added to the insert medium of the ex vivo transwell grafts and both the insert and outer medium were analysed for its presence using fluorescence spectroscopy following a number of different incubation times ( Figure 6 ).
The dextrin-Oregon Green was able to pass right through the extracellular matrix of the ex vivo transwell grafts and was detected in the outer medium of the cultures following only 2 hours of incubation with the conjugate (Figure 6 ). Following 24 hours incubation on the filter insert cultures over 13% of the total fluorescence present in the cultures was detected in the outer medium ( Figure 6 ).
Sample
Free solution Aggrecan-hyaluronan Ratio M w = 10K g/mol -1 2.7 x 10 -10 m 2 s -1 2.6 x 10 -11 m 2 s -1 10 M w = 51K g/mol -1 1.0 x 10 -10 m 2 s -1 5.0 x 10 -12 m 2 s -1 20 The lines of best fit have been derived from the analysis using the gel plus coil model as described in the text. Also shown for comparison is the scattering from the dextrin solution. 
A. Transwell Filter Grafts
